carbamates has been researched along with Cold Panniculitis in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Two male patients with stage IV metastatic BRAF-mutated melanoma were treated with a combination of a selective BRAF inhibitor and a selective MEK inhibitor (dabrafenib and trametinib, or encorafenib (LGX818) and binimetinib (MEK162)) within two different clinical trials." | 3.81 | Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor. ( Dummer, R; Galliker, NA; Goldinger, SM; Kamarashev, J; Murer, C, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Galliker, NA | 1 |
Murer, C | 1 |
Kamarashev, J | 1 |
Dummer, R | 1 |
Goldinger, SM | 1 |
1 other study available for carbamates and Cold Panniculitis
Article | Year |
---|---|
Clinical observation of panniculitis in two patients with BRAF-mutated metastatic melanoma treated with a combination of a BRAF inhibitor and a MEK inhibitor.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carbamates; Humans; Imidazole | 2015 |